RaymondHMakMD
Radiation Oncology • Boston, MAThoracic Cancer
Associate Professor of Radiation Oncology, Brigham and Women's Hospital / Dana-Farber Cancer Institute / Harvard Medical School
Dr. Mak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis Street, ASB1 L2
Boston, MA 02115Phone+1 617-632-3591- Is this information wrong?
Summary
- I am an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.
My clinical focus includes the treatment of thoracic malignancies, stereotactic body radiation therapy, and novel image-guided radiation therapy techniques. I led the implementation of the MR-guided radiation therapy program at BWH/DFCI in 2019.
My research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients and applying artificial intelligence techniques to automate radiation therapy planning and improve cancer care.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011- Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2007
Harvard Medical SchoolClass of 2006
Certifications & Licensure
FL State Medical License 2022 - 2026
NH State Medical License 2023 - 2025
CT State Medical License 2022 - 2025
ME State Medical License 2020 - 2025
MA State Medical License 2008 - 2025
RI State Medical License 2021 - 2024
NY State Medical License 2021 - 2023- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC) Start of enrollment: 2012 Nov 01
- Jump: MR Simulation For Radiation Therapy Master Protocol Start of enrollment: 2020 Oct 14
Roles: Contact, Principal Investigator
- CONFIRM: Magnetic Resonance Guided Radiation Therapy Start of enrollment: 2021 May 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Edge roughness quantifies impact of physician variation on training and performance of deep learning auto-segmentation models for the esophagus.Yan, Y., Kehayias, C., He, J., Aerts, H., Guthier, C., Fitzgerald, K., Kann, B., Kozono, D., Mak, R.> ;Scientific Reports. 2024 Jan 30
- Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort St...D'Aiello, A., Owen, D. H., Amin H Nassar, So Yeon Kim, Jacqueline V Aredo, Jamie Feng, Frances Shepherd, Chao Xu, David Kaldas, Jhanelle E Gray, Thomas J Dilling, Joel...> ;Journal of Thoracic Oncology. 2024 Jan 24
- Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART).Grace Lee, Zhaohui Han, Elizabeth Huynh, Michael C Tjong, Daniel N Cagney, Benjamin H Kann, David Kozono, Jonathan E Leeman, Lisa Singer, Christopher L Williams, Raymo...> ;Radiotherapy and Oncology. 2024 Jan 1
- Join now to see all
Journal Articles
- Association of Left Anterior Descending Coronary Artery Radiation Dose with Major Adverse Cardiac Events and Mortality in Patients with Non–Small Cell Lung CancerKatelyn M Atkins, David E Kozono, Elizabeth H Baldini, Raymond H Mak, JAMA Oncology
Press Mentions
‘A Million Data Points’: A 30-Year Long Lung Cancer Study Meets AIApril 6th, 2023- How a New AI Algorithm May Help Streamline Lung Cancer Radiation TherapyOctober 19th, 2022
- AI Quickens CT Lung Cancer Detection by 65%August 25th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
Brigham and Women's HospitalBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
